Adenomyose

Frank Nawroth
In: Springer Reference Medizin · 2019 · pp. 363–369 · doi:10.1007/978-3-662-57636-6_36 · W4255934770
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

This paper reviews current diagnostic aspects and therapeutic options for adenomyosis, noting that a causal therapy is impossible for diffuse forms, especially with fertility desires, and questions remain regarding the effectiveness of some procedures.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

The paper/chapter reviews current knowledge on adenomyosis, focusing on diagnostic aspects and the state of knowledge on different therapeutic options. It summarizes that adenomyosis is thought to account for many clinical symptoms that were originally attributed to endometriosis, and notes that a causal treatment is not possible, particularly for the diffuse form in patients with existing desire for children, while several approaches have unresolved questions regarding effectiveness and clinical relevance. A key limitation is that the chapter emphasizes gaps in evidence and does not present new original study data. Relevance to endometriosis: it explicitly states that many symptoms previously assigned to endometriosis are attributable to adenomyosis, though the paper’s main focus is adenomyosis diagnostics and therapies.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (53)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK